US equities |
MU $928.76 ▲+0.00% SNDK $1,304.84 ▲+0.00% SKHY $145.36 ▲+0.00% TSLA $407.46 ▲+0.00% NVDA $217.94 ▲+0.00% INTC $93.74 ▲+0.00% SPCX $148.58 ▲+0.00% STX $667.85 ▲+0.00%
FinancialContent

Outset Medical, Inc. - Common Stock (NQ:OM)

4.340 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Outset Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Outset Medical to Participate in the 2026 Stifel Healthcare Conference
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Reports Second Quarter 2026 Results
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Present at RBC Global Healthcare Conference
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Reports First-Quarter Results
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Names Derick Elliott as Executive Vice President of Commercial
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standards 
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results
Appoints Medical Technology Veteran Karen N. Prange to Board of Directors 
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
From Pomerantz LLP
Via GlobeNewswire
News headline image
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
From Pomerantz LLP
Via GlobeNewswire
News headline image
Outset Medical Reports Third-Quarter Results
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System
Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology’s Kidney Week 2025 
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Present at the 2025 Stifel Healthcare Conference
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis
Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System 
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization
Company raises 2025 revenue guidance to a range of $122 million to $126 million 
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Names First Chief Nursing Officer
Accomplished nursing executive to lead Outset’s clinical education and support programs for the dialysis nursing community 
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
From iRhythm
Via GlobeNewswire
News headline image
Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
From Outset Medical, Inc.
Via GlobeNewswire
News headline image
Outset Medical Appoints Renee Gaeta as Chief Financial Officer
From Outset Medical, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >